PLXS Form 4: Director Karen Rapp Sells 500 Shares via 10b5-1 Plan

Rhea-AI Filing Summary

Plexus Corp (PLXS) director Karen M. Rapp reported a sale of common stock under a pre-existing Rule 10b5-1 plan. The filing shows a disposition of 500 shares on 08/29/2025 at a reported price of $139 per share. The sale was made pursuant to a plan adopted on February 28, 2024. After the reported transaction Ms. Rapp is shown as beneficially owning 8,865 shares of Plexus common stock, held directly. The Form 4 was signed via attorney-in-fact on 09/02/2025 and was filed as a single reporting person filing.

Positive

• Sale executed under a Rule 10b5-1 plan, indicating a prearranged trading plan
• Transparent reporting with Form 4 disclosing transaction date, price, and post-transaction holdings
• Director retains meaningful equity with 8,865 shares remaining after the sale

Negative

• Insider disposition of shares (500 shares), which reduces insider ownership
• Price information disclosed ($139 per share), providing market-relevant detail about the sale

Insights

Financial Analyst

TL;DR: Routine director sale of 500 shares under a Rule 10b5-1 plan; remaining direct holding 8,865 shares.

The transaction is a non-derivative disposition of 500 Plexus shares at $139 each executed on 08/29/2025 and reported on Form 4. Because the sale was made pursuant to a Rule 10b5-1 plan adopted on 02/28/2024, it represents a prearranged sale framework rather than an ad hoc trading decision. The remaining direct beneficial ownership is reported as 8,865 shares. This disclosure provides transparent information on insider liquidity but does not include any new operational or financial data about the company.

Corporate Governance Expert

TL;DR: Insiders used an established 10b5-1 plan to execute a modest sale; filing appears procedurally compliant.

The Form 4 indicates the director checked the box that the transaction was made pursuant to a 10b5-1 written plan and provided the plan adoption date. The signature via attorney-in-fact is dated 09/02/2025. The filing is a routine disclosure required by Section 16 and shows ongoing compliance with insider-trading reporting obligations. No indication of amendments or joint filers is present.

Insider Trade Summary

Net Seller: 500 shares ($69,500)

Net Sell 1 txn

Insider Rapp Karen Marie

Role Director

Sold 500 shs ($70K)

Type	Security	Shares	Price	Value
Sale	Common Stock, $.01 par value	500	$139.00	$70K

Holdings After Transaction: Common Stock, $.01 par value — 8,865 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rapp Karen Marie

(Last) (First) (Middle)

ONE PLEXUS WAY

(Street)

NEENAH WI 54956

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PLEXUS CORP [ PLXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.01 par value	08/29/2025		S(1)		500	D	$139	8,865	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares were sold pursuant to a Rule 10b5-1 plan adopted on February 28, 2024.

Remarks:

	/s/ Karen Rapp, by Kate A. Gitter, Attorney-in-Fact	09/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Karen M. Rapp report on Form 4 for PLXS?

She reported a sale of 500 shares of Plexus common stock on 08/29/2025 at a price of $139 per share under a Rule 10b5-1 plan.

Was the sale by the PLXS director preplanned?

Yes. The Form 4 states the shares were sold pursuant to a Rule 10b5-1 plan adopted on 02/28/2024.

How many Plexus shares does Karen Rapp own after the transaction?

The filing shows she beneficially owns 8,865 shares following the reported sale.

Who signed the Form 4 and when was it filed?

The Form 4 was signed /s/ Karen Rapp, by Kate A. Gitter, Attorney-in-Fact and dated 09/02/2025.

Is this Form 4 a joint filing or by a single reporting person?

The filing indicates it was made by one reporting person (single filer).